News Bigfoot seals funding for artificial pancreas device Funds will go towards the final development of its smartloop solution.
Views & Analysis Measuring the cost of diabetes Can patient education programmes start reducing the burden?
Views & Analysis The 'game changers' in diabetes: Novo and Lilly battle it ou... Two diabetes drugs, Lilly and Boehringer Ingelheim’s (BI) Jardiance and Novo Nordisk’s Victoza, have shown they can go beyond lowering blood sugar, and actually save lives and cut heart attacks
Views & Analysis Digital health round-up: a new dawn in diabetes care, and mo... A round-up of this week’s top digital healthcare news. Marco Ricci reports.
Views & Analysis The first ever ‘artificial pancreas’ is here - the iPhone of... Medtronic's hybrid closed loop device is the first step towards a true 'artificial pancreas'
News J&J's long-lasting diabetes combo approved in US Company looks to new drugs as US Remicade competition looms.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
